(PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study
Presentation: Risk mitigation when switching – Germany's experience within the wider European perspective
Fusafungine | C33H57N3O9 - PubChem
Bioparox FUSAFUNGINUM Nasal Spray 50mg / 10ml LABORATORY SERVIER
Cochrane
Oral rinses, mouthwashes and sprays for improving recovery following tonsillectomy - Fedorowicz, Z - 2013 | Cochrane Library
Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays | SpringerLink
Toxins | Free Full-Text | Emerging Fusarium and Alternaria Mycotoxins: Occurrence, Toxicity and Toxicokinetics | HTML
Bioparox (Fusafungine) | Buy online
Fusafungine-containing medicines - start of referral
LOCABIOTAL ® - Foglietto Illustrativo
Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market added... - Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market
Fusafungine - Wikipedia
How to improve current therapeutic standards in upper respiratory infections: value of fusafungine
Fusafungine Art 31 - Notification
Enniatin-containing solutions for oromucosal use: Quality-by-design ex-vivo transmucosal risk assessment of composition variability - ScienceDirect
Locabiotal (discontinued in the UK - December 2005)
Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink
A General Practice Assessment of Locabiotal in the Treatment of Upper Respiratory Tract Infections
Bioactive Peptide Natural Products as Lead Structures for Medicinal Use | Accounts of Chemical Research
Locabiotal van de markt
